# K252269: FINDER Flu A&B/SARS-CoV-2 Test

- Pathway: 510(k) (Dual Track)
- Applicant: Baebies, Inc.
- Decided: Mar 30, 2026 after 252 days
- Product code: QOF (Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents)
- Device class: 2
- Regulation: 21 CFR 866.3981
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to DEN200031 (2021). 2 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K220963: Simplexa COVID-19 & Flu A/B Direct, Diasorin Molecular, LLC (2023) Summary page 6.

## Most influential descendants
- K261837: FINDER Flu A&B/SARS-CoV-2 Test (2026), 0 descendants of its own

## Indications for use
The FINDER Flu A&B/SARS-CoV-2 Test is an automated, multiplexed, real-time RT-PCR test performed on the FINDER instrument and is intended for the simultaneous qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A, and influenza B viral nucleic acid in nasopharyngeal swab (NPS) specimens from individuals with signs and symptoms of respiratory tract infection. Clinical signs and symptoms of respiratory tract infection due to SARS-CoV-2 and influenza can be similar. The FINDER Flu A&B/SARS-CoV-2 Test is intended for use as an aid in the differential diagnosis of SARS-CoV-2, influenza A, and/or influenza B infection if used in conjunction with other clinical and epidemiological information, and laboratory findings. SARS-CoV-2, influenza A and influenza B viral nucleic acid are generally detectable in NPS specimens during the acute phase of infection. Positive results do not rule out co-infection with other organisms. The agent(s) detected by the FINDER Flu A&B/SARS-CoV-2 Test may not be the definite cause of disease. Negative results do not preclude SARS-CoV-2, influenza A, and/or influenza B infection. The results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions.

Source page: https://510kreport.com/device/K252269
Methodology: https://510kreport.com/methodology